ID   CYFP1_HUMAN             Reviewed;        1253 AA.
AC   Q7L576; A8K6D9; Q14467; Q5IED0; Q6ZSX1; Q9BSD9; Q9BVC7;
DT   06-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   28-JUN-2023, entry version 166.
DE   RecName: Full=Cytoplasmic FMR1-interacting protein 1;
DE   AltName: Full=Specifically Rac1-associated protein 1;
DE            Short=Sra-1;
DE   AltName: Full=p140sra-1;
GN   Name=CYFIP1 {ECO:0000312|HGNC:HGNC:13759};
GN   Synonyms=KIAA0068 {ECO:0000312|EMBL:BAA07552.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAW51476.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND VARIANT SER-820.
RA   Jiang Y.-H., Beaudet A.L.;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAA07552.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow {ECO:0000269|PubMed:7584044};
RX   PubMed=7584044; DOI=10.1093/dnares/1.5.223;
RA   Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S., Seki N.,
RA   Kawarabayasi Y., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. II. The
RT   coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 1:223-229(1994).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:BAC86825.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   SER-820.
RC   TISSUE=Brain {ECO:0000312|EMBL:BAC86825.1}, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAW51476.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAH05097.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH05097.1}, and Placenta
RC   {ECO:0000312|EMBL:AAH01306.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAW51476.1}
RP   PROTEIN SEQUENCE OF 50-58; 111-130; 151-163; 366-377; 441-448; 505-515;
RP   564-573; 754-760; 815-826; 867-877; 1054-1076; 1211-1224 AND 1228-1240, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma, and Hepatoma;
RA   Bienvenut W.V., Claeys D., Boldt K., von Kriegsheim A.F., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [7] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=9417078; DOI=10.1074/jbc.273.1.291;
RA   Kobayashi K., Kuroda S., Fukata M., Nakamura T., Nagase T., Nomura N.,
RA   Matsuura Y., Yoshida-Kubomura N., Iwamatsu A., Kaibuchi K.;
RT   "p140Sra-1 (specifically Rac1-associated protein) is a novel specific
RT   target for Rac1 small GTPase.";
RL   J. Biol. Chem. 273:291-295(1998).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH DPYSL2.
RX   PubMed=16260607; DOI=10.1128/mcb.25.22.9920-9935.2005;
RA   Kawano Y., Yoshimura T., Tsuboi D., Kawabata S., Kaneko-Kawano T.,
RA   Shirataki H., Takenawa T., Kaibuchi K.;
RT   "CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/WAVE1
RT   complex and axon formation.";
RL   Mol. Cell. Biol. 25:9920-9935(2005).
RN   [9]
RP   IDENTIFICATION IN THE WAVE2 COMPLEX.
RX   PubMed=16417406; DOI=10.1371/journal.pbio.0040038;
RA   Weiner O.D., Rentel M.C., Ott A., Brown G.E., Jedrychowski M., Yaffe M.B.,
RA   Gygi S.P., Cantley L.C., Bourne H.R., Kirschner M.W.;
RT   "Hem-1 complexes are essential for Rac activation, actin polymerization,
RT   and myosin regulation during neutrophil chemotaxis.";
RL   PLoS Biol. 4:E38-E38(2006).
RN   [10]
RP   FUNCTION.
RX   PubMed=19524508; DOI=10.1016/j.cell.2009.04.013;
RA   Silva J.M., Ezhkova E., Silva J., Heart S., Castillo M., Campos Y.,
RA   Castro V., Bonilla F., Cordon-Cardo C., Muthuswamy S.K., Powers S.,
RA   Fuchs E., Hannon G.J.;
RT   "Cyfip1 is a putative invasion suppressor in epithelial cancers.";
RL   Cell 137:1047-1061(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-583 AND THR-1234, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.29 ANGSTROMS) OF WAVE1 COMPLEX, FUNCTION,
RP   INTERACTION WITH RAC1, MUTAGENESIS OF CYS-179; ARG-190; GLU-434; PHE-626;
RP   MET-632; LEU-697; TYR-704; LEU-841 AND 844-PHE-TRP-845, AND SUBUNIT.
RX   PubMed=21107423; DOI=10.1038/nature09623;
RA   Chen Z., Borek D., Padrick S.B., Gomez T.S., Metlagel Z., Ismail A.M.,
RA   Umetani J., Billadeau D.D., Otwinowski Z., Rosen M.K.;
RT   "Structure and control of the actin regulatory WAVE complex.";
RL   Nature 468:533-538(2010).
CC   -!- FUNCTION: Component of the CYFIP1-EIF4E-FMR1 complex which binds to the
CC       mRNA cap and mediates translational repression. In the CYFIP1-EIF4E-
CC       FMR1 complex this subunit is an adapter between EIF4E and FMR1.
CC       Promotes the translation repression activity of FMR1 in brain probably
CC       by mediating its association with EIF4E and mRNA (By similarity).
CC       Regulates formation of membrane ruffles and lamellipodia. Plays a role
CC       in axon outgrowth. Binds to F-actin but not to RNA. Part of the WAVE
CC       complex that regulates actin filament reorganization via its
CC       interaction with the Arp2/3 complex. Actin remodeling activity is
CC       regulated by RAC1. Regulator of epithelial morphogenesis. As component
CC       of the WAVE1 complex, required for BDNF-NTRK2 endocytic trafficking and
CC       signaling from early endosomes (By similarity). May act as an invasion
CC       suppressor in cancers. {ECO:0000250|UniProtKB:Q7TMB8,
CC       ECO:0000269|PubMed:16260607, ECO:0000269|PubMed:19524508,
CC       ECO:0000269|PubMed:21107423, ECO:0000269|PubMed:9417078}.
CC   -!- SUBUNIT: Component of the WAVE1 complex composed of ABI2, CYFIP1 or
CC       CYFIP2, BRK1, NCKAP1 and WASF1/WAVE1. Within the complex, a heterodimer
CC       containing NCKAP1 and CYFIP1 interacts with a heterotrimer formed by
CC       WAVE1, ABI2 and BRK1. Component of the CYFIP1-EIF4E-FMR1 complex which
CC       is composed of CYFIP, EIF4E and FMR1. Interacts with FMR1 but does not
CC       bind to related proteins FXR1 or FXR2. Interaction with EIF4E
CC       stimulates FMR1 binding. Component of the WAVE2 complex composed of
CC       ABI1, CYFIP1/SRA1, NCKAP1/NAP1 (NCKAP1l/HEM1 in hematopoietic cells)
CC       and WASF2/WAVE2 (PubMed:16417406). Interacts with the active GTP-bound
CC       form of RAC1. Interacts through its C-terminus with the C-terminus of
CC       DPYSL2/CRMP2 which is necessary for DPYSL2-induced axon outgrowth.
CC       Interacts with NYAP1, NYAP2 and MYO16. Interacts with TMEM108 (via N-
CC       terminus); the interaction associates TMEM108 with the WAVE1 complex
CC       (By similarity). {ECO:0000250|UniProtKB:Q7TMB8,
CC       ECO:0000269|PubMed:16260607, ECO:0000269|PubMed:16417406,
CC       ECO:0000269|PubMed:21107423}.
CC   -!- INTERACTION:
CC       Q7L576; P01023: A2M; NbExp=3; IntAct=EBI-1048143, EBI-640741;
CC       Q7L576; Q06787: FMR1; NbExp=4; IntAct=EBI-1048143, EBI-366305;
CC       Q7L576; O60333-2: KIF1B; NbExp=3; IntAct=EBI-1048143, EBI-10975473;
CC       Q7L576; O14901: KLF11; NbExp=3; IntAct=EBI-1048143, EBI-948266;
CC       Q7L576; P51608: MECP2; NbExp=3; IntAct=EBI-1048143, EBI-1189067;
CC       Q7L576; Q9Y2A7: NCKAP1; NbExp=5; IntAct=EBI-1048143, EBI-389845;
CC       Q7L576; P07196: NEFL; NbExp=3; IntAct=EBI-1048143, EBI-475646;
CC       Q7L576; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-1048143, EBI-5235340;
CC       Q7L576; O76024: WFS1; NbExp=3; IntAct=EBI-1048143, EBI-720609;
CC       Q7L576; P63073: Eif4e; Xeno; NbExp=2; IntAct=EBI-1048143, EBI-2000006;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q7TMB8}.
CC       Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q7TMB8}. Cell
CC       projection, lamellipodium {ECO:0000250|UniProtKB:Q7TMB8}. Cell
CC       projection, ruffle {ECO:0000250|UniProtKB:Q7TMB8}. Synapse, synaptosome
CC       {ECO:0000250|UniProtKB:Q7TMB8}. Note=Highly expressed in the
CC       perinuclear region (By similarity). Enriched in synaptosomes (By
CC       similarity). Also enriched in membrane ruffles and at the tips of
CC       lamellipodia (By similarity). {ECO:0000250|UniProtKB:Q7TMB8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=3;
CC         IsoId=Q7L576-1; Sequence=Displayed;
CC       Name=2; Synonyms=4;
CC         IsoId=Q7L576-2; Sequence=VSP_052346, VSP_052347;
CC       Name=3; Synonyms=5;
CC         IsoId=Q7L576-3; Sequence=VSP_052345;
CC   -!- MISCELLANEOUS: Breakpoint hotspot for the Prader-Willi/Angelman
CC       syndromes and may be implicated in autism. Commonly altered in tumors.
CC   -!- SIMILARITY: Belongs to the CYFIP family. {ECO:0000255}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA07552.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY763577; AAW51476.1; -; mRNA.
DR   EMBL; AY763578; AAW51477.1; -; mRNA.
DR   EMBL; AY763579; AAW51478.1; -; mRNA.
DR   EMBL; AY763580; AAW51479.1; -; mRNA.
DR   EMBL; D38549; BAA07552.1; ALT_INIT; mRNA.
DR   EMBL; AK127094; BAC86825.1; -; mRNA.
DR   EMBL; AK291604; BAF84293.1; -; mRNA.
DR   EMBL; CH471258; EAW65555.1; -; Genomic_DNA.
DR   EMBL; BC001306; AAH01306.2; -; mRNA.
DR   EMBL; BC005097; AAH05097.1; -; mRNA.
DR   CCDS; CCDS73695.1; -. [Q7L576-2]
DR   CCDS; CCDS73696.1; -. [Q7L576-1]
DR   RefSeq; NP_001028200.1; NM_001033028.1. [Q7L576-2]
DR   RefSeq; NP_001274739.1; NM_001287810.2. [Q7L576-1]
DR   RefSeq; NP_001311049.1; NM_001324120.1. [Q7L576-1]
DR   RefSeq; NP_001311052.1; NM_001324123.1. [Q7L576-1]
DR   RefSeq; NP_055423.1; NM_014608.4. [Q7L576-1]
DR   PDB; 3P8C; X-ray; 2.29 A; A=1-1253.
DR   PDB; 4N78; X-ray; 2.43 A; A=1-1253.
DR   PDB; 7USC; EM; 3.00 A; A=1-1253.
DR   PDB; 7USD; EM; 3.00 A; A=1-1253.
DR   PDB; 7USE; EM; 3.00 A; A=1-1253.
DR   PDBsum; 3P8C; -.
DR   PDBsum; 4N78; -.
DR   PDBsum; 7USC; -.
DR   PDBsum; 7USD; -.
DR   PDBsum; 7USE; -.
DR   AlphaFoldDB; Q7L576; -.
DR   SMR; Q7L576; -.
DR   BioGRID; 116800; 167.
DR   CORUM; Q7L576; -.
DR   DIP; DIP-38873N; -.
DR   IntAct; Q7L576; 79.
DR   MINT; Q7L576; -.
DR   STRING; 9606.ENSP00000481038; -.
DR   GlyConnect; 1168; 1 N-Linked glycan (1 site).
DR   GlyCosmos; Q7L576; 1 site, 1 glycan.
DR   GlyGen; Q7L576; 2 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q7L576; -.
DR   MetOSite; Q7L576; -.
DR   PhosphoSitePlus; Q7L576; -.
DR   SwissPalm; Q7L576; -.
DR   BioMuta; CYFIP1; -.
DR   DMDM; 74738589; -.
DR   EPD; Q7L576; -.
DR   jPOST; Q7L576; -.
DR   MassIVE; Q7L576; -.
DR   MaxQB; Q7L576; -.
DR   PaxDb; Q7L576; -.
DR   PeptideAtlas; Q7L576; -.
DR   ProteomicsDB; 68792; -. [Q7L576-1]
DR   ProteomicsDB; 68793; -. [Q7L576-2]
DR   ProteomicsDB; 68794; -. [Q7L576-3]
DR   Antibodypedia; 72407; 141 antibodies from 27 providers.
DR   DNASU; 23191; -.
DR   Ensembl; ENST00000610365.4; ENSP00000478779.1; ENSG00000273749.5. [Q7L576-1]
DR   Ensembl; ENST00000617556.4; ENSP00000480525.1; ENSG00000273749.5. [Q7L576-2]
DR   Ensembl; ENST00000617928.5; ENSP00000481038.1; ENSG00000273749.5. [Q7L576-1]
DR   Ensembl; ENST00000671714.1; ENSP00000500331.1; ENSG00000288461.1. [Q7L576-1]
DR   Ensembl; ENST00000672091.1; ENSP00000499947.1; ENSG00000288461.1. [Q7L576-1]
DR   GeneID; 23191; -.
DR   KEGG; hsa:23191; -.
DR   MANE-Select; ENST00000617928.5; ENSP00000481038.1; NM_014608.6; NP_055423.1.
DR   UCSC; uc001yus.5; human. [Q7L576-1]
DR   AGR; HGNC:13759; -.
DR   CTD; 23191; -.
DR   DisGeNET; 23191; -.
DR   GeneCards; CYFIP1; -.
DR   HGNC; HGNC:13759; CYFIP1.
DR   HPA; ENSG00000273749; Low tissue specificity.
DR   MIM; 606322; gene.
DR   neXtProt; NX_Q7L576; -.
DR   OpenTargets; ENSG00000273749; -.
DR   PharmGKB; PA38367; -.
DR   VEuPathDB; HostDB:ENSG00000273749; -.
DR   eggNOG; KOG3534; Eukaryota.
DR   GeneTree; ENSGT00500000044831; -.
DR   HOGENOM; CLU_002688_2_1_1; -.
DR   InParanoid; Q7L576; -.
DR   OMA; HKESFFY; -.
DR   OrthoDB; 446059at2759; -.
DR   PhylomeDB; Q7L576; -.
DR   TreeFam; TF312925; -.
DR   PathwayCommons; Q7L576; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013404; RAC2 GTPase cycle.
DR   Reactome; R-HSA-9013408; RHOG GTPase cycle.
DR   Reactome; R-HSA-9013423; RAC3 GTPase cycle.
DR   Reactome; R-HSA-9664422; FCGR3A-mediated phagocytosis.
DR   SignaLink; Q7L576; -.
DR   SIGNOR; Q7L576; -.
DR   BioGRID-ORCS; 23191; 276 hits in 1157 CRISPR screens.
DR   ChiTaRS; CYFIP1; human.
DR   EvolutionaryTrace; Q7L576; -.
DR   GeneWiki; CYFIP1; -.
DR   GenomeRNAi; 23191; -.
DR   Pharos; Q7L576; Tbio.
DR   PRO; PR:Q7L576; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q7L576; protein.
DR   Bgee; ENSG00000273749; Expressed in esophagus squamous epithelium and 209 other tissues.
DR   ExpressionAtlas; Q7L576; baseline and differential.
DR   Genevisible; Q7L576; HS.
DR   GO; GO:0044295; C:axonal growth cone; IEA:Ensembl.
DR   GO; GO:0090724; C:central region of growth cone; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0044294; C:dendritic growth cone; IEA:Ensembl.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0060076; C:excitatory synapse; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0032433; C:filopodium tip; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0005845; C:mRNA cap binding complex; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0090725; C:peripheral region of growth cone; IEA:Ensembl.
DR   GO; GO:0001726; C:ruffle; ISS:UniProtKB.
DR   GO; GO:0031209; C:SCAR complex; IMP:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0000340; F:RNA 7-methylguanosine cap binding; IBA:GO_Central.
DR   GO; GO:0031267; F:small GTPase binding; ISS:UniProtKB.
DR   GO; GO:0045182; F:translation regulator activity; IEA:Ensembl.
DR   GO; GO:0048675; P:axon extension; IMP:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0000902; P:cell morphogenesis; IBA:GO_Central.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0050890; P:cognition; IMP:UniProtKB.
DR   GO; GO:0097484; P:dendrite extension; IEA:Ensembl.
DR   GO; GO:0030032; P:lamellipodium assembly; ISS:UniProtKB.
DR   GO; GO:0099563; P:modification of synaptic structure; IBA:GO_Central.
DR   GO; GO:1903422; P:negative regulation of synaptic vesicle recycling; IEA:Ensembl.
DR   GO; GO:2000601; P:positive regulation of Arp2/3 complex-mediated actin nucleation; IMP:UniProtKB.
DR   GO; GO:0045773; P:positive regulation of axon extension; IEA:Ensembl.
DR   GO; GO:1900006; P:positive regulation of dendrite development; IEA:Ensembl.
DR   GO; GO:0010592; P:positive regulation of lamellipodium assembly; IDA:ARUK-UCL.
DR   GO; GO:0051388; P:positive regulation of neurotrophin TRK receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:1900029; P:positive regulation of ruffle assembly; IEA:Ensembl.
DR   GO; GO:0016601; P:Rac protein signal transduction; IMP:UniProtKB.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IEA:InterPro.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   GO; GO:1905274; P:regulation of modification of postsynaptic actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0031641; P:regulation of myelination; IEA:Ensembl.
DR   GO; GO:0006417; P:regulation of translation; IBA:GO_Central.
DR   GO; GO:0099578; P:regulation of translation at postsynapse, modulating synaptic transmission; IEA:Ensembl.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0031529; P:ruffle organization; ISS:UniProtKB.
DR   InterPro; IPR009828; CYRIA/CYRIB_Rac1-bd.
DR   InterPro; IPR008081; Cytoplasmic_FMR1-int.
DR   PANTHER; PTHR12195:SF4; CYTOPLASMIC FMR1-INTERACTING PROTEIN 1; 1.
DR   PANTHER; PTHR12195; CYTOPLASMIC FMR1-INTERACTING PROTEIN-RELATED; 1.
DR   Pfam; PF07159; CYRIA-B_Rac1-bd; 1.
DR   Pfam; PF05994; FragX_IP; 1.
DR   PIRSF; PIRSF008153; FMR1_interacting; 1.
DR   PRINTS; PR01698; CYTOFMRPINTP.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Alternative splicing; Cell projection;
KW   Cell shape; Cytoplasm; Developmental protein; Differentiation;
KW   Direct protein sequencing; Neurogenesis; Phosphoprotein;
KW   Reference proteome; Synapse; Synaptosome.
FT   CHAIN           1..1253
FT                   /note="Cytoplasmic FMR1-interacting protein 1"
FT                   /id="PRO_0000279706"
FT   MOD_RES         583
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1234
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..806
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_052345"
FT   VAR_SEQ         1..431
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.1"
FT                   /id="VSP_052346"
FT   VAR_SEQ         432..557
FT                   /note="AEEYERATRYNYTSEEKFALVEVIAMIKGLQVLMGRMESVFNHAIRHTVYAA
FT                   LQDFSQVTLREPLRQAIKKKKNVIQSVLQAIRKTVCDWETGHEPFNDPALRGEKDPKSG
FT                   FDIKVPRRAVGPSST -> MAESLGSAELLRQLKSLGMERLLHAVNTFLRQSCTYLPLL
FT                   TFGGKTSFVSLDVYGTEANCSATSCSFPKAAATWPRRQAPGPLGELVRGPPDQGVAEQS
FT                   FSHGLFEFGITNVPCIFSPPQMFPWII (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.1"
FT                   /id="VSP_052347"
FT   VARIANT         532
FT                   /note="A -> P (in dbSNP:rs34683919)"
FT                   /id="VAR_053849"
FT   VARIANT         820
FT                   /note="G -> D (in dbSNP:rs17137190)"
FT                   /id="VAR_053850"
FT   VARIANT         820
FT                   /note="G -> S (in dbSNP:rs7170637)"
FT                   /evidence="ECO:0000269|PubMed:14702039, ECO:0000269|Ref.1"
FT                   /id="VAR_053851"
FT   MUTAGEN         179
FT                   /note="C->R: Reduced interaction with RAC1."
FT                   /evidence="ECO:0000269|PubMed:21107423"
FT   MUTAGEN         190
FT                   /note="R->D: Reduced interaction with RAC1."
FT                   /evidence="ECO:0000269|PubMed:21107423"
FT   MUTAGEN         434
FT                   /note="E->K: Reduced interaction with RAC1; when associated
FT                   with A-626."
FT                   /evidence="ECO:0000269|PubMed:21107423"
FT   MUTAGEN         626
FT                   /note="F->A: Reduced interaction with RAC1; when associated
FT                   with K-434."
FT                   /evidence="ECO:0000269|PubMed:21107423"
FT   MUTAGEN         632
FT                   /note="M->D: Reduced interaction with RAC1."
FT                   /evidence="ECO:0000269|PubMed:21107423"
FT   MUTAGEN         697
FT                   /note="L->D: Constitutive induction of the formation of
FT                   actin filaments; when associated with D-704."
FT                   /evidence="ECO:0000269|PubMed:21107423"
FT   MUTAGEN         704
FT                   /note="Y->D: Constitutive induction of the formation of
FT                   actin filaments; when associated with D-697."
FT                   /evidence="ECO:0000269|PubMed:21107423"
FT   MUTAGEN         841
FT                   /note="L->A: Constitutive induction of the formation of
FT                   actin filaments; when associated with 844-A-A-845."
FT                   /evidence="ECO:0000269|PubMed:21107423"
FT   MUTAGEN         844..845
FT                   /note="FW->AA: Constitutive induction of the formation of
FT                   actin filaments; when associated with A-841."
FT                   /evidence="ECO:0000269|PubMed:21107423"
FT   CONFLICT        583
FT                   /note="S -> N (in Ref. 1; AAW51478 and 3; BAC86825)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        898
FT                   /note="Y -> H (in Ref. 1; AAW51478 and 3; BAC86825)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        930
FT                   /note="M -> R (in Ref. 1; AAW51478 and 3; BAC86825)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1176
FT                   /note="V -> A (in Ref. 1; AAW51479)"
FT                   /evidence="ECO:0000305"
FT   HELIX           7..17
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           59..84
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           90..92
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:7USD"
FT   HELIX           104..143
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           148..150
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           155..177
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           179..193
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            194..196
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           201..215
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          216..218
FT                   /evidence="ECO:0007829|PDB:7USC"
FT   HELIX           219..229
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          231..233
FT                   /evidence="ECO:0007829|PDB:7USD"
FT   HELIX           234..250
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           257..274
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          275..278
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           281..286
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           292..301
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          304..308
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          311..314
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           316..320
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            323..325
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           326..331
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          333..335
FT                   /evidence="ECO:0007829|PDB:7USC"
FT   HELIX           346..365
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           384..417
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            422..424
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          426..428
FT                   /evidence="ECO:0007829|PDB:7USD"
FT   HELIX           434..438
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           440..442
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           445..467
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           469..489
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            490..492
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           493..501
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           505..518
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          522..525
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           531..534
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           556..570
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            580..583
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           586..598
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           599..601
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           602..606
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           608..615
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           619..621
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           625..630
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            631..633
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           640..642
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           644..655
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           658..660
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            661..663
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           664..668
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           670..680
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           685..721
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           725..733
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           747..750
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          755..757
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          760..762
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           764..788
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           792..794
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           795..813
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           821..828
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          832..836
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           838..849
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           851..854
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          855..858
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            859..862
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          863..866
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           869..871
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           885..887
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           892..901
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           902..906
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           911..942
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           944..955
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           965..967
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           969..979
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           981..984
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            987..992
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           993..1025
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1026..1029
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1043..1053
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1055..1057
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1059..1066
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1069..1083
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1086..1088
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          1090..1092
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1093..1101
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   TURN            1107..1110
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          1115..1118
FT                   /evidence="ECO:0007829|PDB:7USC"
FT   STRAND          1121..1123
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1127..1139
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          1144..1146
FT                   /evidence="ECO:0007829|PDB:7USD"
FT   HELIX           1149..1153
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1156..1167
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1171..1177
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   HELIX           1179..1190
FT                   /evidence="ECO:0007829|PDB:3P8C"
FT   STRAND          1195..1198
FT                   /evidence="ECO:0007829|PDB:7USC"
FT   HELIX           1201..1225
FT                   /evidence="ECO:0007829|PDB:3P8C"
SQ   SEQUENCE   1253 AA;  145182 MW;  D8F45E13207BEF16 CRC64;
     MAAQVTLEDA LSNVDLLEEL PLPDQQPCIE PPPSSLLYQP NFNTNFEDRN AFVTGIARYI
     EQATVHSSMN EMLEEGQEYA VMLYTWRSCS RAIPQVKCNE QPNRVEIYEK TVEVLEPEVT
     KLMNFMYFQR NAIERFCGEV RRLCHAERRK DFVSEAYLIT LGKFINMFAV LDELKNMKCS
     VKNDHSAYKR AAQFLRKMAD PQSIQESQNL SMFLANHNKI TQSLQQQLEV ISGYEELLAD
     IVNLCVDYYE NRMYLTPSEK HMLLKVMGFG LYLMDGSVSN IYKLDAKKRI NLSKIDKYFK
     QLQVVPLFGD MQIELARYIK TSAHYEENKS RWTCTSSGSS PQYNICEQMI QIREDHMRFI
     SELARYSNSE VVTGSGRQEA QKTDAEYRKL FDLALQGLQL LSQWSAHVME VYSWKLVHPT
     DKYSNKDCPD SAEEYERATR YNYTSEEKFA LVEVIAMIKG LQVLMGRMES VFNHAIRHTV
     YAALQDFSQV TLREPLRQAI KKKKNVIQSV LQAIRKTVCD WETGHEPFND PALRGEKDPK
     SGFDIKVPRR AVGPSSTQLY MVRTMLESLI ADKSGSKKTL RSSLEGPTIL DIEKFHRESF
     FYTHLINFSE TLQQCCDLSQ LWFREFFLEL TMGRRIQFPI EMSMPWILTD HILETKEASM
     MEYVLYSLDL YNDSAHYALT RFNKQFLYDE IEAEVNLCFD QFVYKLADQI FAYYKVMAGS
     LLLDKRLRSE CKNQGATIHL PPSNRYETLL KQRHVQLLGR SIDLNRLITQ RVSAAMYKSL
     ELAIGRFESE DLTSIVELDG LLEINRMTHK LLSRYLTLDG FDAMFREANH NVSAPYGRIT
     LHVFWELNYD FLPNYCYNGS TNRFVRTVLP FSQEFQRDKQ PNAQPQYLHG SKALNLAYSS
     IYGSYRNFVG PPHFQVICRL LGYQGIAVVM EELLKVVKSL LQGTILQYVK TLMEVMPKIC
     RLPRHEYGSP GILEFFHHQL KDIVEYAELK TVCFQNLREV GNAILFCLLI EQSLSLEEVC
     DLLHAAPFQN ILPRVHVKEG ERLDAKMKRL ESKYAPLHLV PLIERLGTPQ QIAIAREGDL
     LTKERLCCGL SMFEVILTRI RSFLDDPIWR GPLPSNGVMH VDECVEFHRL WSAMQFVYCI
     PVGTHEFTVE QCFGDGLHWA GCMIIVLLGQ QRRFAVLDFC YHLLKVQKHD GKDEIIKNVP
     LKKMVERIRK FQILNDEIIT ILDKYLKSGD GEGTPVEHVR CFQPPIHQSL ASS
//
